Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.88

-1.2%

Dec 22 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Proton who wrote (13627)	1/23/1998 12:36:00 AM
From: Henry Niman	Read Replies (1) of 32384

P2, LGND has several miletones tied to PFE's development of Droloxifene and CP-366,156. I'm sure that an NDA filing for Droloxifene is one, but since the PFE alliance was an osteoporosis drug, I'm not sure how significant a milestone for an NDA for breast cancer would be. They may get a similar or larger payment for Droloxifene moving in Phase III for osteoporosis or CP-366,156 moving into Phase II for osteoporosis.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next